11 Jul Phileo and CanBiocin to expand presence in worldwide companion animal care market
We are thrilled to announce a significant investment by Lesaffre in CanBiocin, a renowned leader in probiotics for companion animals. This bold move represents a major step forward in Phileo’s commitment to addressing the total companion animal care ecosystem with innovative, cutting-edge solutions.
By combining CanBiocin’s expertise in probiotic solutions with Lesaffre’s global reach and nearly two centuries of fermentation know-how, coupled with Phileo’s capacity to innovate, we are poised to deliver transformative products that enhance companion animal health and well-being worldwide.
This investment opens new horizons for Phileo by Lesaffre, and it is even more meaningful when taken in the context of our recent acquisition of a majority stake in Biorigin in Brazil, a specialist in natural-origin ingredients. Together, Phileo, CanBiocin, and Biorigin form a powerhouse of complementary capabilities, enabling us to address the diverse and evolving needs of pet owners and feed producers globally – from premium pet food enhancements to solutions that elevate animal wellness.
As Brice Audren, CEO of Lesaffre, eloquently stated, “This is a bold step for Lesaffre and Phileo by Lesaffre toward the future of pet care innovation.” With a shared commitment to sustainability, innovation, and the highest standards of quality, we are more energized than ever to contribute to better nourishing and protecting the planet.
We look forward to the opportunity to work closely with the teams at Biorigin and CanBiocin, leveraging our combined expertise to realize the full potential of this exciting partnership.
Let’s act with nature for animal care
Press contact Phileo by Lesaffre: Clementine Mariën – c.marien@phileo.lesaffre.com
To learn more about Phileo, please visit www.phileo-lesaffre.com
Sorry, the comment form is closed at this time.